首页> 外文会议>Optics in Health Care and Biomedical Optics: Diagnostics and Treatment II pt.2; Progress in Biomedical Optics and Imaging; vol.5, no.33 >Clinical Research on Erythrocyte Deformability with different Doses He-Ne Exposure in Patient with ischemia disease
【24h】

Clinical Research on Erythrocyte Deformability with different Doses He-Ne Exposure in Patient with ischemia disease

机译:不同剂量He-Ne暴露对缺血性疾病患者红细胞变形能力的临床研究

获取原文
获取原文并翻译 | 示例

摘要

[AIM]: The aim of this study was to test human erythrocyte deformability with the exposure of erythrocyte from apoplexy patient and other ischemia diseases, contracted with normal donors' blood sample, and the doses-effect of Low-power He_Ne laser in vitro were discussed.[METHOD]: Fresh blood sample from adult health donors and patients with different diseases such as apoplexy, diabetes, heart block etc in emergency department were collected and divided into different groups in which there were no less than 6 persons. Fresh human blood samples were irradiated with a He-Ne laser(Lamba=632.8nm), power output around 4.5MW ,9MW,15mW,and18mW, et al, exposure time from 7.5min,15min, and 30min, operating in continuous wave. Measurements of human erythrocyte deformability were taken. [RESULT]: Erythrocyte deformability appearance shown some different in the health contracted group and the other ischemia disease group. Some notice difference also shown among some disease group with nonirradiation and the same disease group with laser irradiation . The dose-effects of He-Ne laser therapy was discussed on the further research on the erythrocyte deformability of blood sample from patients with apoplexy disease treated with He-Ne laser at different doses, and a certain optimal doses which could take a beneficial effect in clinic were speculated on. [CONCULSION]: This study revealed that the He-Ne laser have some different effects on erythrocyte deformability in vitro, which were related with the disease condition , red cell state, and outpower-doses ,ct al closely.
机译:[目的]:本研究的目的是通过中风患者和其他缺血性疾病暴露的红细胞暴露于正常供血者的血液中,检测人的红细胞变形性,并用低功率He_Ne激光在体外进行剂量效应分析。讨论。[方法]:收集来自成人健康捐献者和急诊科中风,糖尿病,心脏传导阻滞等不同疾病患者的新鲜血液样本,并将其分为不少于6人的不同组。用He-Ne激光(Lamba = 632.8nm)照射新鲜的人体血液样品,输出功率分别为4.5MW,9MW,15mW和18mW等,暴露时间分别为7.5min,15min和30min,以连续波操作。测量人的红细胞变形能力。 [结果]:健康收缩组和其他缺血性疾病组的红细胞可变形性外观有所不同。未照射的某些疾病组与激光照射的同一疾病组之间也表现出明显的差异。讨论了氦氖激光治疗的剂量效应,并进一步研究了不同剂量氦氖激光治疗中风病患者血液样本中红细胞的变形能力,并确定了一定的最佳剂量,可以在治疗中发挥有益作用。推测诊所。 [结论]:这项研究表明,氦氖激光在体外对红细胞的可变形性有一些不同的影响,这与疾病状况,红细胞状态和支配剂量密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号